Precipio Inc (NASDAQ:PRPO) — Market Cap & Net Worth
Market Cap & Net Worth: Precipio Inc (PRPO)
Precipio Inc (NASDAQ:PRPO) has a market capitalization of $31.61 Million ($31.61 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23629 globally and #5065 in its home market, demonstrating a -3.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Precipio Inc's stock price $22.26 by its total outstanding shares 1619584 (1.62 Million). Review Precipio Inc (PRPO) financial obligations to assess the company's total debt and financial obligations.
Precipio Inc Market Cap History: 2015 to 2026
Precipio Inc's market capitalization history from 2015 to 2026. Data shows change from $15.60 Billion to $36.04 Million (-42.53% CAGR).
Index Memberships
Precipio Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #679 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #2244 of 3165 |
Weight: Precipio Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Precipio Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Precipio Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
Precipio Inc's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $15.60 Billion | $1.65 Million | -$32.95 Million | 9434.38x | N/A |
| 2016 | $4.14 Billion | $1.56 Million | -$7.62 Million | 2660.35x | N/A |
| 2017 | $583.05 Million | $1.72 Million | -$20.69 Million | 338.39x | N/A |
| 2018 | $74.82 Million | $2.86 Million | -$15.69 Million | 26.13x | N/A |
| 2019 | $66.40 Million | $3.13 Million | -$13.24 Million | 21.24x | N/A |
| 2020 | $67.05 Million | $6.09 Million | -$10.62 Million | 11.01x | N/A |
| 2021 | $51.18 Million | $8.85 Million | -$8.55 Million | 5.78x | N/A |
| 2022 | $17.86 Million | $9.41 Million | -$12.20 Million | 1.90x | N/A |
| 2023 | $10.53 Million | $15.20 Million | -$5.85 Million | 0.69x | N/A |
| 2024 | $8.97 Million | $15.96 Million | -$4.29 Million | 0.56x | N/A |
Competitor Companies of PRPO by Market Capitalization
Companies near Precipio Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Precipio Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Precipio Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Precipio Inc's market cap moved from $15.60 Billion to $ 36.04 Million, with a yearly change of -42.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $36.04 Million | -3.15% |
| 2025 | $37.22 Million | +314.82% |
| 2024 | $8.97 Million | -14.77% |
| 2023 | $10.53 Million | -41.06% |
| 2022 | $17.86 Million | -65.10% |
| 2021 | $51.18 Million | -23.67% |
| 2020 | $67.05 Million | +0.98% |
| 2019 | $66.40 Million | -11.26% |
| 2018 | $74.82 Million | -87.17% |
| 2017 | $583.05 Million | -85.92% |
| 2016 | $4.14 Billion | -73.44% |
| 2015 | $15.60 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Precipio Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.61 Million USD |
| MoneyControl | $31.61 Million USD |
| MarketWatch | $31.61 Million USD |
| marketcap.company | $31.61 Million USD |
| Reuters | $31.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Precipio Inc
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomar… Read more